FY2024 EPS Estimate for ORIC Pharmaceuticals Cut by Analyst
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Investment analysts at Wedbush decreased their FY2024 EPS estimates for ORIC Pharmaceuticals in a report issued on Tuesday, November 12th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($1.82) per share for the year, down from their previous forecast of ($1.73). Wedbush […]
FY2024 EPS Estimate for Target Hospitality Lifted by Analyst
Target Hospitality Corp. (NASDAQ:TH – Free Report) – Investment analysts at Northland Capmk upped their FY2024 earnings per share (EPS) estimates for shares of Target Hospitality in a report issued on Wednesday, November 13th. Northland Capmk analyst G. Gibas now expects that the company will earn $0.65 per share for the year, up from their […]
FY2024 EPS Estimate for Excelerate Energy Reduced by Analyst
Excelerate Energy, Inc. (NYSE:EE – Free Report) – Stock analysts at Northland Capmk reduced their FY2024 EPS estimates for shares of Excelerate Energy in a research report issued on Monday, November 11th. Northland Capmk analyst B. Brooks now expects that the company will post earnings per share of $1.18 for the year, down from their […]
FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Equities researchers at Chardan Capital reduced their FY2025 earnings per share estimates for shares of Krystal Biotech in a note issued to investors on Tuesday, November 5th. Chardan Capital analyst Y. Livshits now expects that the company will post earnings per share of $5.78 for the year, […]
last updated on 15 Nov 14:56